Reducing the Burden of Breast Cancer in Young Women (or RUBY) is a pan-Canadian collaborative comprised of 62 researchers and clinicians at 31 institutions and clinics across Canada, and clinics across Canada, with the common goal of studying breast cancer in young women. Currently under the direction of Dr. Steven Narod (Principal-Investigator, Women’s College Hospital) and Dr. May Lynn Quan (Co-Principal Investigator, University of Calgary), the overall aim of this program is to establish a population-based cohort of 1,500 women newly-diagnosed with breast cancer aged 40 and under.
The 1,500 RUBY participants will be enrolled over five years, during which our team will collect treatment information and details around coping, managing finances, and health literacy. The data will be made available to researchers across Canada to address many questions to help identify optimal treatments for this population and improve their chances of survival.
Women aged 40 and under face unique challenges that are often overlooked in breast cancer care, such as stress from career interruptions, early menopause or diagnosis at the time of pregnancy. Research shows that they also suffer poorer prognosis and outcomes, which may be linked to the current unclear genetic basis of young-onset breast cancer. This suggests that Young Women with Breast Cancer (YWBC) may benefit from different treatments compared to older women.
The differences in treatment may relate to supportive care and self-management, fertility preservation, the influence of a several known genes, the impact of lifestyle and nutrition, the impact of various surgeries and the ramifications of treatment delay. The RUBY study includes four synergistic sub-projects that will focus on these factors individually.
These sub-projects are:
The new knowledge generated from RUBY will be used to help guide provincial policies regarding the optimal treatment of young-onset breast cancer and to improve prognosis and quality of life for these young women.
Visit the RUBY website for more information.
Principal Investigators: May Lynn Quan, Steven Narod
Co-Investigators: Kelly Metcalfe, Christine Friedenreich, Nancy Baxter, Ellen Warner, Mohammad R. Akbari, Ivo Olivotto, Doris Howell
Funded by: Canadian Institutes of Health Research and Canadian Cancer Society ($5,700,00)
Warner E, Yee S, Kennedy E, Glass K, Foong S, Seminsky M, Quan M.L. Oncofertility knowledge, attitudes, and practices of Canadian breast surgeons. Ann Surg Oncol. 2016 Nov;23(12):3850-3859. Epub 2016 Jul 18. Read
Warner E, Yee S, Seminsky M, Glass K, Foong S, Kennedy E, Narod S, Quan M.L. Effect of a knowledge-translation intervention on breast surgeons’ oncofertility attitudes and practices. Ann Surg Oncol. 2020 May;27(5):1645-1652. Epub 2019 Oct 28. Read
Quan M.L, Olivotto I.A, Baxter N.N, Friedenreich C.M, Metcalfe K, Warner E, MacLennan K, Stephen J.E, Akbari M.R, Howell D, Narod S, RUBY site investigators. A pan-Canadian prospective study of young women with breast cancer: the rationale and protocol design for the RUBY study. Curr Oncol. 2020 Oct;27(5):e516-e523. Epub 2020 Oct 1. Read
Carmona CA, Yee S, Seminsky M, Glass K, Foong S, Lipson E, Baxter NN, Fridenreich CM, Metcalfe K, Isherwood S, Akbari M, Narod S, Quan ML, Warner E. Surgeon and patient reports of fertility preservation referral and uptake in a prospective, pan-Canadian study of young women with breast cancer. Ann Surg Oncol. 2022 May;29(5):3022-3033. doi: 10.1245/s10434-021-11254-w. Epub 2022 Jan 9. Read
Carmona CA, Yee S, Seminsky M, Glass K, Foong S, Lipson E, Baxter NN, Friedenreich CM, Metcalfe K, Isherwood S, Akbari MR, Narod S, Quan ML, Warner E. ASO Visual Abstract: Surgeon and Patient Reports of Fertility Preservation Referral and Uptake in a Prospective Pan-Canadian Study of Young Women with Breast Cancer. Ann Surg Oncol. 2022 Feb 15. doi: 10.1245/s10434-022-11340-7. (Epub ahead of print). C
Howell DM, Metcalfe K, Kong S, Stephen J, Olivotto I.A, Baxter N, Friedenreich C.M, Warner E, Akbari M.R, McBain K, Narod S, Quan M.L. Risk factors for psychological morbidity and the protective role of coping self-efficacy in young women with breast cancer early in diagnosis: a national multicentre cohort study. Breast Cancer Res Treat. 2022 Apr 24. Online ahead of print. Read
Corter A.L, Speller B, McBain K, Wright F.C, Quan M.L, Kennedy E, Schmocker S, Baxter N.N, RUBY cohort investigators. Evaluating a multidisciplinary cancer conference checklist: Practice versus perceptions. J Multidiscip Healthc. 2019 Nov 1;12:883-891. eCollection 2019. Read
Metcalfe K, Narod SA, Poll A, Hoey C, Warner E, Baxter NN, Isherwood S, MacDougall E, Zemani N, Yang F, Suwito JS, Quan ML, Akbari MR; RUBY Study Group. Frequency of germline pathogenic variants in breast cancer predisposing genes in a national cohort of young women with breast cancer. Br J Cancer. 2026 Jun 23. doi: 10.1038/s41416-026-03502-1. Epub ahead of print. PMID: 42337046. Read